Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

NIH seeks licensees for method of treating allergies and HIV

Feb. 24, 1997

Antisense compound for asthma shows promise

Feb. 21, 1997

Efficacy of leukotriene antagonist in asthma

Feb. 19, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Positive phase II results reported for LiquiVent

Feb. 12, 1997

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

Dual leukotriene/thromboxane antagonists described by Hokuriku

Feb. 10, 1997

Antiallergic/antiinflammatory agents from Senju

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...